Company Overview and News
New Delhi: Global airlines’ body IATA has strongly opposed levying of GST on international air tickets, dubbing the taxation as “wrong” as it contravenes many global agreements to which India is a party.
(Reuters) - Following is a summary of commercial aircraft deals announced by Airbus (AIR.PA) and Boeing (BA.N) at the Farnborough Airshow in southern England.
AL ALLLZ 532617 JETAIRWAYS
The Boeing Company (BA - Free Report) recently announced that it signed a deal involving orders and commitments for delivering up to 78 Boeing airplanes to Air Lease Corporation (AL - Free Report) , at the 2018 Farnborough International Airshow. The deal worth $9.6 billion at current list prices included 75 737 MAX 8s and three 787-9 Dreamliners, thereby expanding Air Lease Corporation’s 737 MAX portfolio to 213 jets.
AL NOC ALLLZ BOE 532617 JETAIRWAYS TXT BA
Mumbai: InterGlobe Aviation’s IndiGo retained its position as the market leader among domestic airlines as it carried 46.73 lakh local passengers in June, achieving a market share of 41.3%, according to the data issued Wednesday by civil aviation regulator, Directorate General of Civil Aviation (DGCA).
INDIGO 532617 JETAIRWAYS 539448
On Wednesday, Vistara announced a 24-hour flash monsoon sale with all-inclusive one-way fares across all its cabin classes. Many airlines like Jet Airways and IndiGo have already announced monsoon discount packages in their efforts to attract more passengers.
The share price of aviation companies declined up to 3.5 percent intraday on Wednesday after the fall in their passenger load factor for June month.
INDIGO 532617 JETAIRWAYS 539448
New Delhi: Full service carrier Jet Airways is offering up to 30% discount on domestic as well as international flights under a sale which will be open for bookings till 23 July, 2018. According to the airline’s website, “up to 30% discount is applicable on base fare in Première and Economy from India to destinations across its international network on flights operated by Jet Airways and to select destinations in Europe on flights operated by Jet Airways and codeshare partners Air France and KLM Royal Dutch Airlines.
New Delhi: Full-service airline Vistara has announced a 24-hour monsoon flash sale, offering all-inclusive one-way fares “discounted as much as 50% relative to normal fares”. Under this new Vistara flash sale, the airline is offering economy class fares starting from Rs 1,299, premium economy fares from Rs 2,449 and business class fares starting at Rs 6,099. The Vistara offer is applicable for travel between 25th July, 2018 and 11th October, 2018, both dates included.
C6L 532617 JETAIRWAYS SINGY SINGF
The Boeing Company (BA - Free Report) has recently signed a deal with Jet Airways for delivering 75 of its 737 MAX 8 aircraft to India’s second largest airline company. This order is in sync with the airlines’ latest rush to expand its network to meet the surging demand in the fastest-growing aviation market in the world. The deal, valued at $8.8 billion at current list prices, is the fourth consecutive agreement between Boeing and Jet Airways over the last year, taking the purchase tally to 225 aircraft.
NOC BOE 532617 EGL JETAIRWAYS TXT BA
Naresh Goyal-promoted Jet Airways today signed a formal agreement with Boeing Co to acquire an additional 75 latest single-aisle 737 Max aircraft valued at $8.8 billion at current list prices.
BOE 532617 JETAIRWAYS BA
After starting the week on a negative note, the market on Tuesday looked to reclaim its positive momentum from last week, backed by sharp gains in midcaps. The Sensex managed to end the day almost 200 points higher, while the Nifty managed to end above 11,000-mark.
IOC 500469 532617 TCHQY HINDUNILVR FEDA 532755 532187 532461 FEDS 500696 500477 FEDERALBNK ASHOKLEY SBAZ INDIGO INDUSINDBK JETAIRWAYS FDBAY 530965 AKLD TECHM 539448 PNJZY PNB AKLS
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...